Analyst Reco. CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.56 ^USD	0.00%		-9.03%	-37.00%

Apr. 16	CareDx Appoints John Hanna as CEO, President	MT
Apr. 16	CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Upgrades CareDx to Overweight From Equalweight, Price Target is $10	Nov. 09	MT
Raymond James Upgrades CareDx to Outperform From Market Perform, Price Target is $12	23-08-15	MT
BTIG Research Downgrades CareDx to Neutral From Buy	23-05-11	MT
Goldman Sachs Lowers Price Target on CareDx to $13 From $25, Maintains Buy Rating	23-03-07	MT
Stephens Downgrades CareDx to Equalweight From Overweight, Adjusts Price Target to $9 From $19	23-03-07	MT
Craig-Hallum Downgrades CareDx to Hold From Buy, Adjusts Price Target to $9 From $26	23-03-03	MT
Raymond James Downgrades CareDx to Market Perform From Strong Buy, $24 Price Target	23-03-03	MT
Craig-Hallum Adjusts CareDx's Price Target to $26 From $32, Keeps Buy Rating	23-02-28	MT
BTIG Adjusts Price Target on CareDx to $25 From $28, Maintains Buy Rating	23-02-28	MT
Goldman Sachs Adjusts CareDx's Price Target to $25 From $29, Maintains Buy Rating	23-02-28	MT
Goldman Sachs Adjusts Price Target on CareDx to $29 From $40, Maintains Buy Rating	23-02-06	MT
Raymond James Adjusts CareDx's Price Target to $24 From $26, Maintains Strong Buy Rating	23-01-31	MT
BTIG Adjusts Price Target on CareDx to $28 From $37, Maintains Buy Rating	22-11-07	MT
Raymond James Adjusts Price Target on CareDx to $35 From $45, Reiterates Strong Buy Rating	22-08-10	MT
Goldman Sachs Adjusts Price Target for CareDx to $45 From $50, Maintains Buy Rating	22-07-18	MT
Stephens Initiates CareDx at Overweight with $50 Price Target	22-04-25	MT
Raymond James Adjusts CareDx's Price Target to $52 from $90, Maintains Strong Buy Rating	22-02-25	MT
Raymond James Adjusts CareDx PT to $90 From $108, Maintains Strong Buy Rating	21-10-29	MT
CAREDX : Piper Sandler Adjusts Price Target on CareDx to $110 From $100, Reiterates Overweight Rating	21-07-30	MT
CAREDX : BTIG Analyst Assumes Coverage on CareDx at Buy, Sets $115 Price Target	21-07-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. CareDx, Inc

Equities

CDNA

US14167L1035

Analyst Reco.

Filters